Coronavirus Disease 2019 (COVID-19) Information for Cardiologists -Systematic Literature Review and Additional Analysis-

被引:16
|
作者
Sugimoto, Tadafumi [1 ]
Mizuno, Atsushi [2 ,3 ,4 ,21 ]
Kishi, Takuya [5 ,21 ]
Ito, Naoya [6 ]
Matsumoto, Chisa [7 ,21 ]
Fukuda, Memori [8 ,21 ]
Kagiyama, Nobuyuki [9 ]
Shibata, Tatsuhiro [10 ]
Ohmori, Takashi [11 ]
Oishi, Shogo [12 ]
Fuse, Jun [13 ]
Kida, Keisuke [14 ]
Kawai, Fujimi [15 ]
Ishida, Mari [16 ,21 ]
Sanada, Shoji [17 ,21 ]
Komuro, Issei [18 ,19 ]
Node, Koichi [19 ,20 ,21 ]
机构
[1] Mie Univ Hosp, Dept Clin Lab, Tsu, Mie, Japan
[2] St Lukes Int Hosp, Dept Cardiol, Tokyo, Japan
[3] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA
[4] Juntendo Univ, Dept Cardiol, Tokyo, Japan
[5] Int Univ Hlth & Welf, Dept Grad Sch Med Cardiol, Okawa, Japan
[6] Shizuoka Canc Ctr Hosp, Div Infect Dis, Shizuoka, Japan
[7] Tokyo Med Univ, Ctr Hlth Surveillance & Prevent Med, Dept Cardiol, Tokyo, Japan
[8] Keio Univ Hosp, Dept Cardiol, Tokyo, Japan
[9] West Virginia Univ, Heart & Vasc Inst, Morgantown, WV 26506 USA
[10] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka, Japan
[11] Iizuka Hosp, Dept Transit Med & Palliaitve Care, Iizuka, Fukuoka, Japan
[12] Himeji Cardiovasc Ctr, Dept Cardiol, Himeji, Hyogo, Japan
[13] Well Being Clin Komazawa Pk, Tokyo, Japan
[14] St Marianna Univ, Sch Med, Dept Pharmacol, Kawasaki, Kanagawa, Japan
[15] St Lukes Int Univ Lib, Tokyo, Japan
[16] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Hiroshima, Japan
[17] Osaka City Univ Hosp, Ctr Clin Res & Innovat, Osaka, Japan
[18] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan
[19] Japanese Circulat Soc, Execut Comm, Tokyo, Japan
[20] Saga Univ, Dept Cardiovasc Med, Saga, Japan
[21] Japanese Circulat Soc, Informat & Commun Comm, Tokyo, Japan
关键词
Cardiologist; COVID-19; Heart failure; Infection; Myocardial injury;
D O I
10.1253/circj.CJ-20-0302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the rapidly increasing attention being given to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, more commonly known as coronavirus disease 2019 (COVID-19), the relationship between cardiovascular disease and COVID-19 has not been fully described. Methods and Results: A systematic review was undertaken to summarize the important aspects of COVID-19 for cardiologists. Protection both for patients and healthcare providers, indication for treatments, collaboration with other departments and hospitals, and regular update of information are essentials to front COVID-19 patients. Conclusions: Because the chief manifestations of COVID-19 infection are respiratory and acute respiratory distress syndrome, cardiologists do not see infected patients directly. Cardiologists need to be better prepared regarding standard disinfection procedures, and be aware of the indications for extracorporeal membrane oxygenation and its use in the critical care setting.
引用
收藏
页码:1039 / +
页数:15
相关论文
共 50 条
  • [21] Coronavirus disease 2019 (COVID-19) in children: a systematic review of imaging findings
    Shelmerdine, Susan C.
    Lovrenski, Jovan
    Caro-Dominguez, Pablo
    Toso, Seema
    PEDIATRIC RADIOLOGY, 2020, 50 (09) : 1217 - 1230
  • [22] The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post-COVID-19 conditions: A systematic literature review and meta-analysis
    Marra, Alexandre R.
    Kobayashi, Takaaki
    Suzuki, Hiroyuki
    Alsuhaibani, Mohammed
    Hasegawa, Shinya
    Tholany, Joseph
    Perencevich, Eli
    Maezato, Aline Miho
    Ricardo, Victoria Catharina Volpe
    Salinas, Jorge L.
    Edmond, Michael B.
    Rizzo, Luiz Vicente
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [23] Comprehensive review of coronavirus disease 2019 (COVID-19)
    Chauhan, Shaylika
    BIOMEDICAL JOURNAL, 2020, 43 (04) : 334 - 340
  • [24] A Review of Coronavirus Disease-2019 (COVID-19)
    Tanu Singhal
    The Indian Journal of Pediatrics, 2020, 87 : 281 - 286
  • [25] A Review of Coronavirus Disease-2019 (COVID-19)
    Singhal, Tanu
    INDIAN JOURNAL OF PEDIATRICS, 2020, 87 (04): : 281 - 286
  • [26] A Review of Coronavirus Disease 2019 (COVID-19) for Pharmacists
    Sucher, Allana J.
    Sayre, T. J.
    Dagen, Kyle
    Vasas, Taylor
    Chahine, Elias B.
    US PHARMACIST, 2020, 45 (7-8) : 46 - 57
  • [27] The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis
    Marra, Alexandre R.
    Kobayashi, Takaaki
    Suzuki, Hiroyuki
    Alsuhaibani, Mohammed
    Schweizer, Marin L.
    Diekema, Daniel J.
    Tofaneto, Bruna Marques
    Bariani, Luigi Makowski
    Auler, Mariana de Amorim
    Salinas, Jorge L.
    Edmond, Michael B.
    Pinho, Joao Renato Rebello
    Rizzo, Luiz Vicente
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2022, 2 (01):
  • [28] CARDIOVASCULAR OUTCOMES ASSOCIATED WITH CORONAVIRUS DISEASE 2019 (COVID-19): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Alkofide, H.
    Almesned, R.
    Alnoghaimshi, L.
    Alkherb, Z.
    Alhindi, G.
    Korayem, G.
    VALUE IN HEALTH, 2021, 24 : S74 - S74
  • [29] Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis
    Okoli, George N.
    Rabbani, Rasheda
    Al-Juboori, Amenah
    Copstein, Leslie
    Askin, Nicole
    Abou-Setta, Ahmed M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (02) : 267 - 278
  • [30] Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis
    Ahmed Yassin
    Mohammed Nawaiseh
    Ala Shaban
    Khalid Alsherbini
    Khalid El-Salem
    Ola Soudah
    Mohammad Abu-Rub
    BMC Neurology, 21